Mobilaser Study to Help with People Who are Having Problems with Their Gait

Overview

About this study

Does use of the Mobilaser reduce freezing of gait (FOG) and stride reduction in patients with Parkinson's disease and Parkinsonism.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Parkinsonian patients with Freezing of Gait or Gait hesitation.
Must have evidence of bradykinesia ambulating (stride reduction or reduced arm swing)
Must have a constant caregiver

Exclusion Criteria:

No cardiopulmonary contraindications to ambulation, e.g., unstable angina pectoris;
Severe arthritis;
Cerebellar or sensory ataxia;
Recent knee or hip surgery

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Jacksonville, Fla. Mayo Clinic principal investigator Jay van Gerpen, M.D.	Closed for enrollment

Mayo Clinic Location

Status

Jacksonville, Fla.

Mayo Clinic principal investigator

Jay van Gerpen, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials